Search
for
Sort by
Research 361–390 of 1000+
- Melan-A Positive cells significantly expressed in immune-targeted follicles of Alopecia Areata
- Adenomatous Polyposis Coli (APC) Is Required for Normal Development of Skin and Thymus
- Update on the dermatologic use of systemic glucocorticosteroids
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- A Guide to Studying Human Hair Follicle Cycling In Vivo
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Adverse cutaneous effects of psychotropic medications
- Melanocytes and Vitiligo (and Hair Graying)
- The evolution of primary multimodality treatment in resectable breast cancer
- Impact of Chemotherapeutic Drug on People living with Cancer
- P131 Menstrual irregularity in hirsute women
- Dermatologic Adverse Events from Cancer Treatments
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Novel adenosine triphosphate (ATP)-binding cassette, subfamily A, member 12 (ABCA12) mutations associated with congenital ichthyosiform erythroderma
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Color-transition sign: A useful trichoscopic finding for differentiating alopecia areata incognita from telogen effluvium
- Immunopathogenesis of Primary Cicatricial Alopecia
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Clinical and biological impact of the exposome on the skin
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- An Update on Drug-Induced Pigmentation
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Docetaxel-induced Psoriasis